Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

KVVLA2TTH1

Millipore

Durapore® 0.1 µm, Opticap® XLT Capsule

Opticap® XLT 20, cartridge nominal length 20 in. (50 cm), filter diam. 4.2 in. (10.7 cm)

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
23151806

Materiali

polypropylene filter
polypropylene housing
polypropylene support
silicone seal

Livello qualitativo

Conformità normativa

FDA 21CFR177-182 (all component materials)

Sterilità

non-sterile

Compatibilità con la sterilizzazione

autoclavable compatible

Nome Commerciale

Opticap® XLT 20

Caratteristiche

hydrophilic

Produttore/marchio commerciale

Opticap®

Parametri

≤40 mL/min air diffusion at 3.9 bar (56 psig) and 23 °C (in water)
1 bar max. inlet pressure (15 psi) at 80 °C
1.7 bar max. differential pressure (25 psid) at 80 °C (Forward:)
2.8 bar max. inlet pressure (40 psi) at 60 °C
25 °C max. inlet temp.
3.5 bar max. differential pressure (50 psid) at 25 °C (Reverse; intermittent)
5.5 bar max. differential pressure (80 psid) at 25 °C (Forward:)
5.5 bar max. inlet pressure (80 psi) at 23 °C
80 psig max. inlet pressure

tecniche

sterile filtration: suitable

Larghezza

6.9 in.

Lunghezza nominale della cartuccia

20 in. (50 cm)

device L

62.5 cm (24.6 in.)

device size

20 in.

Diam. filtro

4.2 in. (10.7 cm)

Superficie filtrante

1.4 m2

Diam. connessione ingresso

1-1/2 in.

inlet to outlet width

17.5 cm (6.9 in.)

Diam. connessione uscita

5/8 in.

Impurezze

≤0.5 EU/mL bacterial endotoxins (LAL test, aqueous extraction)
<0.5 EU/mL bacterial endotoxins (LAL test, sample aqueous extraction)

Matrice

Durapore®

Dimensione pori

0.1 μm pore size

Punto di bolla

≥4830 mbar (70 psig), air with water at 23 °C

Raccordi

16 mm (5/8 in.) fitting (hose barb inlet/oulet)
38 mm (1 1/2 in.) fitting (sanitary flange inlet/oulet)
1/4 in. fitting (vent/drain hose barb with double O-ring seal)
(38 mm (1 1/2 in.) Sanitary Flange Inlet and 16 mm (5?8 in.) Hose Barb Outlet)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Descrizione generale

Device Configuration: Capsule

Confezionamento

Double Easy-Open bag

Nota sulla preparazione

Sterilization Method:
3 autoclave cycles of 60min at 126°C; not in-line steam sterilizable

This product was manufactured with a Durapore® membrane which meets the criteria for a "non-fiber releasing" filter as defined in 21CFR210.3(b)(6).

Risultati analitici

Bacterial Retention: Samples were quantitatively retentive of a minimum Brevundimonas diminuta challenge concentration of 1 x 107 CFU/cm2 using ASTM® F838 methodology.
Gravimetric Extractables: ≤ 50 mg per capsule after 24 hours in water at controlled room temperature.
Will meet the USP Oxidizable Substances Test requirements after a water flush of ≥ 2 L

Altre note

Directions for Use:

  • Organism Retention: Microorganism
  • Mode of Action: Filtration (size exclusion)
  • Application: BioProcessing
  • Intended Use: Reduction or removal of microorganism/bioburden
  • Instructions for Use: Please refer Wetting Instructions for Filter Units with Durapore® Membrane user guide
  • Storage Statement: Store in dry location
  • Disposal Statement: Dispose of in accordance with applicable federal, state and local regulations

Note legali

ASTM is a registered trademark of American Society for Testing and Materials
Durapore is a registered trademark of Merck KGaA, Darmstadt, Germany
OPTICAP is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Motore di ricerca dei prodotti.


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Articoli

Before adoption of single-use technologies in biomanufacturing, manufacturers must assess the risk to the drug product from potential leachables. This article highlights a general approach based on the United States Pharmacopeia (USP).

This page provides an overview of USP <87>, <88>, and <1031>, compares bioreactivity testing, and describes the transition of our organization towards in vitro test methods.

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.